Skip to main content

Table 5 Frequency of each criterion of MS according to ATP III and IDF in men with and without clinical lipodystrophy

From: Impact of Lipodystrophy on the prevalence and components of metabolic syndrome in HIV-infected patients

Men
ATPIII IDF
MS criteria Total Without CL With CL p value Total Without CL With CL p value
WC [n, (%)] 43 (18.0%) 21 (24.7%) 22 (14.3%) 0.045 98 (41.0%) 42 (49.4%) 56 (36.4%) 0.050
TG [n, (%)] 197 (82.4%) 65 (76.5%) 132 (85.7%) 0.072 197 (82.4%) 65 (76.5%) 132 (85.7%) 0.072
HDL [n, (%)] 181 (75.7%) 62 (72.9%) 119 (77.3%) 0.455 181 (75.7%) 62 (72.9%) 119 (77.3%) 0.455
BP [n, (%)] 111 (46.6%) 41 (48.2%) 70 (45.8%) 0.713 111 (46.6%) 41 (48.2%) 70 (45.8%) 0.713
GLU [n, (%)] 107 (44.8%) 35 (41.2%) 72 (46.8%) 0.407 103 (43.1%) 35 (41.2%) 68 (44.2%) 0.656
Number of MS criteria         
0 8 (3.3) 3 (3.5) 5 (3.3)   8 (3.4) 3 (3.5) 5 (3.3)  
1 29 (12.1) 15 (17.6) 14 (9.2)   24 (10.1) 11 (12.9) 13 (8.5)  
2 72 (30.1) 21 (24.7) 51 (33.3)   60 (25.29 19 (22.4) 41 (26.8)  
3 67 (28.5) 23 (27.1) 44 (28.8)   70 (29.4) 22 (25.9) 48 (31.4)  
4 48 (20.1) 17 (20.0) 31 (20.3)   48 (20.2) 20 (23.5) 28 (18.3)  
5 14 (5.9) 6 (7.1) 8 (5.2) 0.411 28 (11.8) 10 (11.8) 18 (11.8) 0.718
  1. Note - CL = Clinical lipodystrophy MS = Metabolic syndrome; ATPIII = Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults; IDF = International Diabetes Federation; WC = waist circumference; TG = triglycerides; HDL = HDL cholesterol; BP = blood pressure; GLU = glucose.